Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinlu Pharmaceutical Technology Co., Ltd. is a pharmaceutical research and development company based in Jinan, Shandong Province, China. Founded in 2021, the company specializes in providing Contract Research Organization (CRO) services and developing high-end generic drugs. Its core competencies include drug synthesis, formulation development, and regulatory submission for chemical drugs. The company's portfolio features several significant generic products in the fields of oncology, cardiovascular health, and metabolic diseases, such as Apalutamide, Abiraterone Acetate, and Ezetimibe. Shandong Xinlu Pharmaceutical Technology collaborates with major domestic pharmaceutical manufacturers to facilitate the commercialization of its developed therapies. The company is headquartered in the Yinfeng International Bio-city, a prominent biotechnology hub in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinlu Pharmaceutical Technology.